China SXT Pharmaceuticals News

China SXT Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Forsakringsaktiebolaget Avanza Pension(1,29%)

Aug 15 09:47 ET

China SXT Pharmaceuticals | 20-F: FY2024 Annual Report

Aug 13 16:19 ET

China SXT Pharmaceuticals | NT 20-F: Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F

Jul 31 16:18 ET

China SXT Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Forsakringsaktiebolaget Avanza Pension(5,42%)

May 31 10:38 ET

China SXT Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

May 14 16:21 ET

China SXT Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 5 09:28 ET

China SXT Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Forsakringsaktiebolaget Avanza Pension(2,38%)

Feb 9 10:20 ET

China SXT Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Forsakringsaktiebolaget Avanza Pension(5,07%)

Feb 9 06:39 ET

China SXT Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jan 11 00:00 ET

China SXT Pharmaceuticals | 20-F: FY2023 Annual Report

Jul 31, 2023 16:15 ET

China SXT Pharmaceuticals | UPLOAD: Others

Jun 2, 2023 11:33 ET

China SXT Pharmaceuticals | 20-F/A: Registration statement / Annual report / Transition report (Amendment)

May 19, 2023 17:16 ET

China SXT Pharmaceuticals | CORRESP: CORRESP

Apr 13, 2023 17:25 ET

China SXT Pharmaceuticals | UPLOAD: Others

Mar 31, 2023 13:30 ET

China SXT Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Streeterville Capital LLC(9.99*%),Streeterville Management LLC(9.99*%), etc.

Mar 29, 2023 14:19 ET

China SXT Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Streeterville Capital LLC(0%),Streeterville Management LLC(0%), etc.

Mar 29, 2023 13:48 ET

China SXT Pharmaceuticals | 424B7: Prospectus

Mar 24, 2023 18:54 ET

China SXT Pharmaceuticals | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]

Mar 23, 2023 06:02 ET

China SXT Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

Feb 28, 2023 16:05 ET

China SXT Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

Feb 24, 2023 17:15 ET